Get Fit Bharat

Category: CSP

HomeCSP

ALISA BANK PLC MANAGER TRANSACTIONS 21.11.2024 AT 11.50 EET Person subject to the notification requirementName: Tero WeckrothPosition: Member of the Board/Deputy memberIssuer: Alisa Pankki OyjLEI: 743700VK1NB8HRGTQH74 Notification type: INITIAL NOTIFICATIONReference number: 85561/5/4   Transaction date: 2024-11-20-24Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000170915Nature of transaction: ACQUISITION  Transaction details(1): Volume: 25000 …

Odfjell has announced the approval of a new expansion project at Odfjell Terminals Korea (OTK). The project comprises a new tank pit of ten tanks and will significantly broaden services and product handling capacity at the leading Ulsan terminal. The project, named E5, will increase OTK’s capacity by 28% to exceed …

ANNOUNCEMENT NO. 252 – 21 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S …

Gasum’s pooling service offers a unique opportunity for vessels running on conventional fuels to benefit from the use of renewable bio-LNG. Energy company Gasum has signed a Letter of Intent (LOI) with Finnish shipping company Viking Line on joining Gasum’s FuelEU Maritime pooling service. Viking Line uses LNG-powered vessels to …

Linköping, Sweden – November 21, 2024 – At this year’s Radiological Society of North America’s annual meeting (RSNA), international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will showcase its latest developments to make the radiologists’ workflows faster. By providing all essential diagnostic tools in one application and …

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced new preclinical data indicating that drug candidate CS585, a novel prostacyclin (IP) receptor agonist, inhibits platelet activation and clot formation up to 24 hours post-administration. …